First use of 18F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy

Brain and Behavior

Volumn 4, Issue 2, 2014, Pages 312-315

  Oborski, Matthew J ^a   Laymon, Charles M ^a,b   Lieberman, Frank S ^b   Drappatz, Jan ^b   Hamilton, Ronald L ^b   Mountz, James M ^b  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Early therapy response assessment; Glioblastoma multiforme; Positron emission tomography

Indexed keywords

18F 2 (5 FLUORO PENTYL) 2 METHYLMALONIC ACID; KI 67 ANTIGEN; RADIOPHARMACEUTICAL AGENT; TEMOZOLOMIDE; UNCLASSIFIED DRUG; 5-FLUOROPENTYL-2-METHYLMALONIC ACID; ALKYLATING AGENT; DACARBAZINE; METHYLMALONIC ACID;

ADULT; APOPTOSIS; ARTICLE; CASE REPORT; DRUG UPTAKE; EXTERNAL BEAM RADIOTHERAPY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; NICK END LABELING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; AGED; ANALOGS AND DERIVATIVES; BRAIN NEOPLASMS; DRUG EFFECTS; PROCEDURES; RADIATION RESPONSE; SCINTISCANNING; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BRAIN NEOPLASMS; DACARBAZINE; GLIOBLASTOMA; HUMANS; MALE; METHYLMALONIC ACID; POSITRON-EMISSION TOMOGRAPHY; TREATMENT OUTCOME;

EID: 84896876442     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.217     Document Type: Article

References (10)

1. Blankenberg, F. G. 2008. In vivo detection of apoptosis. J. Nucl. Med. 49(Suppl. 2):81S-95S.
2. Cohen, A., A. Shirvan, G. Levin, H. Grimberg, A. Reshef, and I. Ziv 2009. From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res. 19:625-637.
3. Fernandez-Luna, J. L. 2007. Apoptosis regulators as targets for cancer therapy. Clin. Trans. Oncol. 9:555-562.
4. Hoglund, J., A. Shirvan, G. Antoni, S. A. Gustavsson, B. Langstrom, and A. Ringheim, et al. 2011. 18F-ML-10, a PET tracer for apoptosis: first human study. J. Nucl. Med. 52:720-725.
5. Hygino da Cruz, L. C., Jr. I. Rodriguez, R. C. Domingues, E. L. Gasparetto, and A. G. Sorensen 2011. Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am. J. Neuroradiol. 32:1978-1985.
6. Meggiato, T., F. Calabrese, M. Valente, E. Favaretto, E. Baliello, and G. Del Favero 2000. Spontaneous apoptosis and proliferation in human pancreatic cancer. Pancreas 20:117-122.
7. Reshef, A., A. Shirvan, H. Grimberg, G. Levin, A. Cohen, A. Mayk, et al. 2007. Novel molecular imaging of cell death in experimental cerebral stroke. Brain Res. 1144:156-164.
8. Reshef, A., A. Shirvan, E. Shohami, H. Grimberg, G. Levin, A. Cohen, et al. 2008. Targeting cell death in vivo in experimental traumatic brain injury by a novel molecular probe. J. Neurotrauma 25:569-580.
9. Wen, P. Y., D. R. Macdonald, D. A. Reardon, T. F. Cloughesy, A. G. Sorensen, E. Galanis, et al. 2010. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J. Clin. Oncol. 28:1963-1972.
10. Witham, T. F., H. Okada, W. Fellows, R. L. Hamilton, J. C. Flickinger, W. H. Chambers, et al. 2005. The characterization of tumor apoptosis after experimental radiosurgery. Stereotact. Funct. Neurosurg. 83:17-24.